Flu-like symptoms and reactions at the injection site of Teriflunomide for treatment of those with Multiple Sclerosis occur less frequently than under beta interferon 1a, whereas diarrhea and hair loss are more frequent. There are no relevant differences in other aspects of treatment.
Fuente : http://feeds.sciencedaily.com/~r/sciencedaily/~3/n...
Fuente : http://feeds.sciencedaily.com/~r/sciencedaily/~3/n...